Rituximab Induced Interstitial Lung Disease in Patients with Non-Hodgkin’s Lymphoma: A Clinical Study of Six Cases and Review of the Literature

Table 2

Patients with severe and nonsevere ILD: clinical features.

Parameter	Severe R-ILD ()	Nonsevere ILD ()
Age > 45 years	3 (75%)	2 (100%)
Male gender	3 (75%)	2 (100%)
Histopathology (DLBCL)	4 (100%)	0
Stage III	2	1
Stage IV	2	1
Acute onset of dyspnea	3	0
High grade fever	4 (100%)	0